Clinical Trial: A Multiple Dose Study of LY3502970 in Healthy Overweight and Obese Participants
Study Status: COMPLETED
Recruit Status: COMPLETED
Condition: Healthy
Study Type: INTERVENTIONAL
Official Title: A Multiple Dose Study to Assess the Pharmacokinetics, Safety, and Tolerability of Tablet and Capsule Formulations of LY3502970 in Healthy Overweight and Obese Participants
Brief Summary:
The main purpose of this study is to evaluate how much LY3502970 gets into the bloodstream and how long it takes the body to eliminate when administered orally as tablet and capsule formulations along with effect of food on LY3502970 in healthy overweight and obese participants.The study will also evaluate the safety and tolerability of LY3502970 in these participants.The study is conducted in two parts (part A and B) and will last up to 135 days including the screening period.
Read more